Citation Tools

QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX

Download to a citation manager

Cite this article as:
Monk BJ, Huang H, Cella D, et al
QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX